These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33747206)

  • 1. Protein-loss of SWI/SNF-complex core subunits influences prognosis dependent on histological subtypes of intra- and extrahepatic cholangiocarcinoma.
    Wagner BJ; Plum PS; Apel K; Scherer M; Buchner D; Brinkmann S; Buettner R; Stippel D; Quaas A; Drebber U
    Oncol Lett; 2021 May; 21(5):349. PubMed ID: 33747206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
    Raab JR; Runge JS; Spear CC; Magnuson T
    Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study.
    Chen IY; Ettel MG; Bell PD; Huber AR; Findeis-Hosey JJ; Wang W; Hezel AF; Dunne RF; Drage MG; Agostini-Vulaj D
    Hum Pathol; 2024 Feb; 144():40-45. PubMed ID: 38307342
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Namjan A; Techasen A; Loilome W; Sa-Ngaimwibool P; Jusakul A
    PeerJ; 2020; 8():e10464. PubMed ID: 33344089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
    Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M
    Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
    Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
    Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
    Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
    Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation.
    Marquez SB; Thompson KW; Lu L; Reisman D
    Front Oncol; 2014; 4():372. PubMed ID: 25774356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions
    Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
    Oncoscience; 2016; 3(11-12):337-350. PubMed ID: 28105458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers.
    Savas S; Skardasi G
    Crit Rev Oncol Hematol; 2018 Mar; 123():114-131. PubMed ID: 29482773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
    Alpsoy A; Dykhuizen EC
    J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
    Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
    Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-targeted metabolomics of
    Banerjee R; Bultman SJ; Holley D; Hillhouse C; Bain JR; Newgard CB; Muehlbauer MJ; Willis MS
    Metabolomics; 2015 Oct; 11(5):1287-1301. PubMed ID: 26392817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.
    Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A
    Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
    Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
    Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
    Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
    Kimura A; Arakawa N; Hirano H
    J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.